Navigation Links
CardioMEMS CFO, Daniel H. Bauer, Wins the Delaney Consulting 2011 Excellence in Finance and Accounting Award

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial Officer, Daniel H. Bauer, has won Delaney Consulting, LLC's 2011 Excellence in Financing and Accounting Award in the fast-growth category. The Delaney awards acknowledge accounting and finance professionals from the Metro Atlanta area who exemplify ethics and excellence in their profession and demonstrate exceptional skill, teamwork, and the advancement and application of technical accounting and financial knowledge.

The award ceremony was held at the City Club of Buckhead on November 16, 2011. Five awards were presented, representing emerging growth, fast growth (under $500 million) and large (over $500 million) businesses. A diversity award and a CFOradio Listener's Choice award were also presented. A panel of professionals representing the finance, accounting, and education fields judged the awards.            

Mr. Bauer began his career at Price Waterhouse and previously served as the Chief Financial Officer for Industriaplex, Granite City Food and Brewery, and Church's Chicken, the largest division of AFC Enterprises. He is currently a board member for the Association for Corporate Growth, a member of the advisory board of Emerge Scholarships, and an alumnus of Leadership Atlanta.

More information on the Delaney Consulting, LLC Excellence in Financing and Accounting Awards can be found at

About Delaney Consulting, LLC
Delaney Consulting, LLC is a financial services and executive search firm that provides financial expertise to help companies achieve their financial goals. Clients engage Delaney CFOs and Controllers for their specialized financial experience and skill, whether needed on an interim, part-time or per-project basis. Clients also use Delaney's retained placement services to fit the unique needs of companies during any stage of their business lifecycle – whether the company is growing, optimizing stability or undergoing challenges.

About CardioMEMS, Inc.
CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist
2. CardioMEMS CFO, Dan Bauer, Wins the Delaney Consulting 2011 Excellence in Finance and Accounting Award
3. The Association of Telecom Professionals Selects Dr. Jay Yadav, CardioMEMS Founder & CEO, as an Atlanta Telecom Professional of the Year in the Industry Innovation Category
4. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
5. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
6. CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle
7. CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist
8. CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle
9. CardioMEMS, Inc. Tops Georgias 2010 Venture Financing List
10. CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company
11. CardioMEMS Recognized by Georgia Bio for Pivotal Strategic Partnership
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Japanese therapeutic drug monitoring market, ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the German ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Therapeutic Drug Monitoring ... Forecasts, Competitive Intelligence, Emerging Opportunities"  report ... ) has announced the addition ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational New Drug ... so important to this key industry segment, Regis Technologies has decided to sponsor and ... 4th at 11am EST. , Federal law does not allow new drugs to cross ...
(Date:11/30/2015)... ... November 30, 2015 , ... SIMmersion’s ... importance to the medical schools of the future. To reach an audience of ... the 2015 ChangeMedEd conference in Chicago, organized by the American Medical Association. ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce their strategic partnership at the Radiological Society of North America (RSNA) ... Winscribe, global providers of cutting-edge dictation and speech-enabled documentation software, announced their ...
(Date:11/30/2015)... ... November 30, 2015 , ... Bayco Products, Inc today announced the introduction of three Nightstick® brand ... choice of three different colors; red ( NSP-1632 ), yellow ( NSP-1634 ) and blue ... hours in constant-on mode, or 27 hours in blinking strobe mode using a fresh set ...
(Date:11/29/2015)... ... November 30, 2015 , ... The Cyber Monday deal is a deep 40% or more discount ... to get gifts for the skin care lover in your circle. Each Christmas, Sublime ... This year, the 3 serums are staples: Collagen, Retinol and Hyaluronic Serums. , Stocking stuffers ...
Breaking Medicine News(10 mins):